Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Friday, May 30, 2008

Aspect Medical to boost U.S. sales force head count

By Mass High Tech Staff

Aspect Medical Systems Inc. plans to expand its sales force to increase adoption of its bispectral index (BIS) technology to monitor patients’ brain activity during anesthesia, the company reports.

The Norwood-based medical devices firm said it will grow its U.S. sales force from 40 people to between 55 and 60 workers over the next three quarters. The expansion will also include a reduction in the size of sales territories to provide enhanced support for customers.

According to Aspect (Nasdaq: ASPM), BIS technology was used in about 17 percent of all U.S. surgical procedures requiring general anesthesia from March 2007 to March 2008.

Aspect, a maker of brain monitors, reported a 2007 profit of $2.3 million on revenue of $97.3 million. The company employs 288 workers. In July 2007, Aspect spent $37.7 million to buy shares of its stock back from Boston Scientific Corp. (NYSE: BSX), after Boston Scientific ended its funding for development of Aspect’s brain monitors for depression, Alzheimer’s disease and other neurological disorders.
 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.